These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10475170)

  • 1. Involvement of the serotonergic neuronal system in phencyclidine-induced place aversion in rats.
    Kitaichi K; Noda Y; Miyamoto Y; Numaguchi A; Osawa H; Hasegawa T; Furukawa H; Nabeshima T
    Behav Brain Res; 1999 Aug; 103(1):105-11. PubMed ID: 10475170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task.
    Noda Y; Nabeshima T
    Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):607-11. PubMed ID: 9819806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
    Kitaichi K; Yamada K; Hasegawa T; Furukawa H; Nabeshima T
    Jpn J Pharmacol; 1994 Oct; 66(2):181-9. PubMed ID: 7532732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute phencyclidine induces aversion, but repeated phencyclidine induces preference in the place conditioning test in rats.
    Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
    Eur J Pharmacol; 1996 Dec; 318(1):7-9. PubMed ID: 9007505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly.
    Noda Y; Miyamoto Y; Mamiya T; Kamei H; Furukawa H; Nabeshima T
    J Pharmacol Exp Ther; 1998 Jul; 286(1):44-51. PubMed ID: 9655840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phencyclidine-induced head-twitch responses as 5-HT2 receptor-mediated behavior in rats.
    Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
    Neurosci Lett; 1987 May; 76(3):335-8. PubMed ID: 3108730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic involvement in phencyclidine-induced behaviors.
    Nabeshima T; Yamaguchi K; Hiramatsu M; Amano M; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1984 Sep; 21(3):401-8. PubMed ID: 6208563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phencyclidine-induced head-weaving and head-twitch through interaction with 5-HT1 and 5-HT2 receptors in reserpinized rats.
    Yamaguchi K; Nabeshima T; Ishikawa K; Yoshida S; Kameyama T
    Neuropharmacology; 1987 Oct; 26(10):1489-97. PubMed ID: 2446188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopaminergic and serotonergic neuronal systems in the prefrontal cortex of rats in phencyclidine-induced behaviors.
    Yamaguchi K; Nabeshima T; Kameyama T
    J Pharmacobiodyn; 1986 Dec; 9(12):987-96. PubMed ID: 3572718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
    Maurel-Remy S; Bervoets K; Millan MJ
    Eur J Pharmacol; 1995 Jul; 280(2):R9-11. PubMed ID: 7589172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
    Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
    Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(4):265-76. PubMed ID: 2418852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The delayed effects of phencyclidine (PCP) disrupt latent inhibition in a conditioned taste aversion paradigm.
    Turgeon SM; Auerbach EA; Heller MA
    Pharmacol Biochem Behav; 1998 Jun; 60(2):553-8. PubMed ID: 9632240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of nitric oxide in phencyclidine-induced place aversion and preference in mice.
    Miyamoto Y; Noda Y; Komori Y; Sugihara H; Furukawa H; Nabeshima T
    Behav Brain Res; 2000 Dec; 116(2):187-96. PubMed ID: 11080550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD; Shannon HE
    Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
    Wang RY; Liang X
    Neuropsychopharmacology; 1998 Jul; 19(1):74-85. PubMed ID: 9608579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
    Kitaichi K; Yamada K; Yoneda Y; Ogita K; Hasegawa T; Furukawa H; Nabeshima T
    Life Sci; 1995; 56(7):531-43. PubMed ID: 7532775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine.
    Amargós-Bosch M; López-Gil X; Artigas F; Adell A
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):565-73. PubMed ID: 16316487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.